Five-time Grand Slam champion Iga Swiatek accepts a one-month suspension in doping case
The International Tennis Integrity Agency says five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine
Five-time Grand Slam champion Iga Swiatek accepted a one-month suspension after testing positive for the banned substance trimetazidine, a heart medication known as TMZ, the International Tennis Integrity Agency announced Thursday.
Swiatek failed an out-of-competition drug test in August, and the ITIA accepted her explanation that the result was unintentional and caused by the contamination of a nonprescription medication, melatonin, that Swiatek was taking for issues with jet lag and sleeping.
It was determined her level of fault was “at the lowest end of the range for no significant fault or negligence,” the ITIA said.
“This experience, the most difficult in my life so far, taught me a lot,” Swiatek, a 23-year-old from Poland, said in a video she posted on social media.
